Page 171 - OR-1-3

Author contributions 5. Means JC, Martinez-Bengochea AL, Louiselle DA, et al.
Rapid and scalable personalized ASO screening in patient-
Conceptualization: All authors derived organoids. Nature. 2025;638(8049):237-243.
Writing – original draft: Xufeng Wan
Writing – review & editing: Zongke Zhou, Duan Wang doi: 10.1038/s41586-024-08462-1
6. Van de Wetering M, Francies HE, Francis JM, et al.
Ethics approval and consent to participate Prospective derivation of a living organoid biobank of
Not applicable. colorectal cancer patients. Cell. 2015;161(4):933-945.
doi: 10.1016/j.cell.2015.03.053
Consent for publication
7. Abutaleb ARA, McNally EM, Khan SS, Anderson AS,
Not applicable. Carr JC, Wilcox JE. Myocarditis in duchenne muscular
dystrophy after changing steroids. JAMA Cardiol. 2018;
Availability of data 3(10):1006-1010.
Not applicable. doi: 10.1001/jamacardio.2018.2695

References 8. Sidhaye J, Knoblich JA. Brain organoids: An ensemble of
bioassays to investigate human neurodevelopment and
1. Wakefield L, Agarwal S, Tanner K. Preclinical models disease. Cell Death Differ. 2021;28(1):52-67.
for drug discovery for metastatic disease. Cell. 2023;
186(8):1792-1813. doi: 10.1038/s41418-020-0566-4
doi: 10.1016/j.cell.2023.02.026 9. Tang XY, Wu S, Wang D, et al. Human organoids in basic
research and clinical applications. Signal Transduct Target
2. Choudhury D, Ashok A, Naing MW. Commercialization of
organoids. Trends Mol Med. 2020;26(3):245-249. Ther. 2022;7(1):168.
doi: 10.1016/j.molmed.2019.12.002 doi: 10.1038/s41392-022-01024-9
3. Wang SQ, Chen JJ, Jiang Y, et al. Targeting GSTP1 as 10. Lindholm MW, Elmén J, Fisker N, et al. PCSK9 LNA
therapeutic strategy against lung adenocarcinoma stemness antisense oligonucleotides induce sustained reduction
and resistance to tyrosine kinase inhibitors. Adv Sci (Weinh). of LDL cholesterol in nonhuman primates. Mol Ther.
2023;10(7):e2205262. 2012;20(2):376-381.
doi: 10.1002/advs.202205262 doi: 10.1038/mt.2011.260
4. Prakash TP, Mullick AE, Lee RG, et al. Fatty acid conjugation 11. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F.
enhances potency of antisense oligonucleotides in muscle. Genome engineering using the CRISPR-Cas9 system. Nat
Nucleic Acids Res. 2019;47(12):6029-6044. Protoc. 2013;8(11):2281-2308.
doi: 10.1093/nar/gkz354 doi: 10.1038/nprot.2013.143

Volume 1 Issue 3 (2025) 4 doi: 10.36922/OR025120012